usdaed

Ladies and gentlemen, let’s examine two contenders who might just rocket into the stratosphere-or crash into the ground with a thud. Buckle up.

Two such entities emerge from the chaos: Tractor Supply (TSCO), custodian of rural America’s quiet resilience, and Kroger (KR), steward of the grocery cart’s sacred duty. One sells the tools of subsistence; the other, the sustenance itself. Together, they form a diadem of dependability in a world where even the moon might forget to rise.

Until now, the pharmaceutical industry had grown accustomed to the rhythm of regulatory approval and clinical trials, where risks were measured and tangible. But the true peril of recent times has come not from the science of medicine, but from the hand of politics. With President Trump’s public vow to lower drug prices and his threats to impose tariffs on pharmaceutical imports, companies like Pfizer faced an uncertain future, their earnings threatened by forces far beyond their control. The political winds had shifted, and there was an undeniable sense of unease in the markets.

To claim the Shiller P/E is a perfect predictor would be to mistake a compass for a map. Yet its track record is troubling. Since 1871, the ratio has exceeded 30 on six occasions. Each was followed by a collapse of 20% or more. The first, in 1929, preceded the Great Depression. The second, in 1999, heralded the dot-com implosion. The third, in 2018, foreshadowed a 20% plunge. The fourth, in 2020, coincided with the pandemic crash. The fifth, in 2022, marked the start of a bear market. And the sixth? It is ongoing, with the ratio now at 40.15.

These are not mere numbers; they are the ghosts of past excesses, whispering warnings in the ears of the present. The Shiller P/E is not a crystal ball, but a rearview mirror. And what it reflects is a pattern as old as capitalism itself: greed, followed by fear, followed by a reckoning.

Consider the “next-big-thing” trends of the past three decades. The internet, blockchain, AI-each has been hailed as a revolution, only to be met with the same cycle of hype and disillusionment. Investors, like children at a candy store, have consistently overestimated the utility of these innovations. AI, for all its promise, remains a box of chocolates: you never know what you’re gonna get.

Loading…

–

Though we’ve lived in this “new normal” since the 1990s, there is little question that stocks are now priced with the optimism of a man who’s just sold his car for a goat. History, that relentless pedant, reminds us that anchoring to such valuations is a fool’s errand. The market is not a machine; it is a theater of human folly, where the final act is always the same: the curtain falls, the lights dim, and the audience is left to count the coins in their pockets.

And yet, the performance continues. The music plays on.